千亿美元！盖茨计划捐出的99%个人财富将怎么花

Core Insights - Bill Gates announced a plan to donate 99% of his personal wealth, estimated at $108 billion, to the Gates Foundation over the next 20 years, with total charitable spending expected to exceed $200 billion by 2045 [1][4][5] - The Gates Foundation aims to accelerate its spending and plans to close by the end of 2045, significantly earlier than the original plan of 20 years after Gates' death [1][4] - The foundation will focus its funding on global health and development, addressing urgent issues exacerbated by reductions in international aid from developed countries [1][7] Funding and Financial Strategy - The Gates Foundation has already donated over $100 billion since its inception 25 years ago, with significant contributions from Warren Buffett, totaling $43 billion [4][5] - The foundation currently holds $77 billion in assets, and Gates plans to continue funding through profits from his ventures in clean energy [5] - The foundation's future spending will be supported by existing funds and ongoing contributions from Gates and other sources [5] Global Health and Development Focus - The foundation's charitable spending will continue to target global health initiatives, having previously supported the creation of organizations like Gavi and the Global Fund to fight AIDS, Tuberculosis, and Malaria, saving approximately 82 million lives [7] - The foundation addresses "market failures" in healthcare, investing in research and development for diseases like malaria, which disproportionately affects low-income regions [7][8] - Gates Foundation's strategic goals include ending preventable maternal and infant deaths, ensuring the next generation is free from deadly infectious diseases, and helping millions escape poverty [8][9] Collaboration and Innovation - The foundation collaborates with various partners, including organizations in China, to develop affordable and effective vaccines, such as the Japanese encephalitis vaccine [8][9] - Gates has expressed a desire to work with Chinese partners to explore cost-effective production of high-quality medical products for global distribution [9]